Thyrocare Technologies fell 9.1 percent as PharmaEasy offers to acquire 66% stake
Published On: Monday, June 28, 2021 | By: Team KnowMyStock
Shares of Thyrocare Technologies dipped 9.1 per cent to Rs 1,317on the BSE in Monday's intra-day after digital healthcare company Pharmeasy announced that it would buy a controlling stake in the diagnostic chain for Rs 4,546 crore.The Delhi-based company would buy 66.1 per cent stake in Thyrocare from promoter A Velumani and his affiliates at Rs 1,300 per share. Dr A Velumani, the founder of Thyrocare, will be separately acquiring a minority non-controlling stake, of less than 5 percent in API Holdings as part of a series of equity investments by existing and new investors of API, the statement added.The proposed deal shocked investors as the deal price was 11% lower than the stock price of the firm.This would be the first ever acquisition of a listed company, by an Indian unicorn, the companies said in a joint statement. "It is the third big-ticket transaction involving an e-pharmacy company," they said.The stock price has surged over 176 percent in last 1 year.
Analysts were of the view that short-term investors should sell their shares considering the difference between the stock price and deal price. There is a lack of clarity from the new management about the future course of action (offer for sale and delisting among others) which is an additional risk for investors, they said.Long-term investors should remain invested and wait for fresh buying opportunities.
We are on Telegram!
JOIN our telegram channel to receive updates on Financial News and Stock and FNO Tips.
Click Here!
Follow Us On:
